EP2115466A4 - Cardiovascular autoimmune disease panel and methods of using same - Google Patents

Cardiovascular autoimmune disease panel and methods of using same

Info

Publication number
EP2115466A4
EP2115466A4 EP07869697A EP07869697A EP2115466A4 EP 2115466 A4 EP2115466 A4 EP 2115466A4 EP 07869697 A EP07869697 A EP 07869697A EP 07869697 A EP07869697 A EP 07869697A EP 2115466 A4 EP2115466 A4 EP 2115466A4
Authority
EP
European Patent Office
Prior art keywords
methods
same
autoimmune disease
disease panel
cardiovascular autoimmune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07869697A
Other languages
German (de)
French (fr)
Other versions
EP2115466A2 (en
Inventor
Phillip G Mattingly
Maciej B Adamczyk
Roy Jeffrey Brashear
Robert C Doss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of EP2115466A2 publication Critical patent/EP2115466A2/en
Publication of EP2115466A4 publication Critical patent/EP2115466A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
EP07869697A 2006-12-22 2007-12-21 Cardiovascular autoimmune disease panel and methods of using same Withdrawn EP2115466A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87660306P 2006-12-22 2006-12-22
PCT/US2007/088477 WO2008080030A2 (en) 2006-12-22 2007-12-21 Cardiovascular autoimmune disease panel and methods of using same

Publications (2)

Publication Number Publication Date
EP2115466A2 EP2115466A2 (en) 2009-11-11
EP2115466A4 true EP2115466A4 (en) 2010-07-28

Family

ID=39563225

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07869697A Withdrawn EP2115466A4 (en) 2006-12-22 2007-12-21 Cardiovascular autoimmune disease panel and methods of using same

Country Status (6)

Country Link
EP (1) EP2115466A4 (en)
JP (1) JP2010515023A (en)
BR (1) BRPI0720215A2 (en)
CA (1) CA2669863A1 (en)
MX (1) MX2009006744A (en)
WO (1) WO2008080030A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2097750A2 (en) 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US20090286256A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratories Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
EP2148203A1 (en) * 2008-07-23 2010-01-27 BRAHMS Aktiengesellschaft Azurophilic granule proteases as markers in cardiological diseases
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
EP2580593A4 (en) * 2010-06-10 2014-04-16 Myra Lipes Diagnosis of myocardial autoimmunity in heart disease
EP3347721B1 (en) 2015-09-09 2020-06-10 Medizinische Hochschule Hannover Diagnosing and treating peripartum cardiomyopathy through the level of plasminogen activator inhibitor
CN112858687B (en) * 2020-12-30 2023-09-15 宁波职业技术学院 Serum amyloid A detection reagent and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100036A1 (en) * 2001-11-08 2003-05-29 Aristo Vojdani Saliva immunoassay for detection of antibodies for cardiovascular disease
WO2007085411A1 (en) * 2006-01-25 2007-08-02 Roche Diagnostics Gmbh Anti-troponin antibodies and cardiovascular risk

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
GB0017641D0 (en) * 2000-07-18 2000-09-06 Medigene Oy Peptides and their use
SE0103754L (en) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptides from apolipoprotein B, use thereof immunization, method of diagnosis or therapeutic treatment of ischemic cardiovascular diseases, and pharmaceutical composition and vaccine containing such peptide
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
DE602004030898D1 (en) * 2003-04-16 2011-02-17 Tasuku Honjo SCREENING METHOD FOR REMEDIES FOR HEART DISEASE AND MEDICAL COMPOSITION FOR THE TREATMENT OF HEART DISEASE
US20050181451A1 (en) * 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
PT1735349E (en) * 2004-04-15 2010-12-14 Athera Biotechnologies Ab Method of assessing the risk of ischemic cardiovascular disease using phosphorylcholine conjugates
JP5350779B2 (en) * 2005-03-31 2013-11-27 ユリウス−マクシミリアンズ−ユニバーシタット ブルツブルグ Means for inhibiting anti-β1 adrenergic receptor antibodies
EP2047263A4 (en) * 2006-07-26 2009-11-18 Inova Diagnostics Inc Compositions and methods for diagnosing patients with acute atherosclerotic syndromes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100036A1 (en) * 2001-11-08 2003-05-29 Aristo Vojdani Saliva immunoassay for detection of antibodies for cardiovascular disease
WO2007085411A1 (en) * 2006-01-25 2007-08-02 Roche Diagnostics Gmbh Anti-troponin antibodies and cardiovascular risk

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
CAFORIO A L P ET AL: "Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies", LUPUS, BASINGSTOKE, GB LNKD- DOI:10.1191/0961203305LU2193OA, vol. 14, no. 9, 1 January 2005 (2005-01-01), pages 652 - 655, XP009124291, ISSN: 0961-2033 *
CAFORIO A L P ET AL: "Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance", EUROPEAN JOURNAL OF HEART FAILURE, ELSEVIER, AMSTERDAM, NL LNKD- DOI:10.1016/S1388-9842(02)00010-7, vol. 4, no. 4, 1 August 2002 (2002-08-01), pages 411 - 417, XP002376773, ISSN: 1388-9842 *
HE ZHONG-MEI ET AL: "Distribution and biological effects of autoantibody against alpha(1),-adrenoceptor in patients with primary hypertension", CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 114, no. 18, suppl, 15 November 2006 (2006-11-15), pages 494, XP009134671, ISSN: 0009-7322 *
LIAO YU-HUA ET AL: "Autoantibodies against the alpha(1)-adrenoceptor related with the increased stroke recurrence in hypertensive patients", CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 112, no. 17, suppl, 16 November 2005 (2005-11-16), pages U402/II - 346, XP009134670, ISSN: 0009-7322 *
LUTHER H P ET AL: "Alpha1-adrenergic receptor antibodies in patients with primary hypertension", HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 29, no. 2, 1 January 1997 (1997-01-01), pages 678 - 682, XP002197208, ISSN: 0194-911X *
MATSUI S ET AL: "Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors", AUTOIMMUNITY, INFORMA HEALTHCARE, GB, vol. 21, no. 2, 1 January 1995 (1995-01-01), pages 85 - 88, XP009134664, ISSN: 0891-6934 *
MICHELS V V ET AL: "Circulating heart autoantibodies in familial as compared with nonfamilial idiopathic dilated cardiomyopathy", MAYO CLINIC PROCEEDINGS, DOWDEN HEALTH MEDIA, INC, US, vol. 69, no. 1, 1 January 1994 (1994-01-01), pages 24 - 27, XP009134672, ISSN: 0025-6196 *
ZHANG LIN ET AL: "Study of autoantibodies against G-protein-coupled beta2- and alpha1-adrenergic and angiotensin II type 1 receptors in patients with dilated cardiomyopathy", ZHONGHUA ZHONGLIU ZAZHI - CHINESE JOURNAL OF ONCOLOGY, ZHONGHUA YIXUEHUI, BEIJING, CN, vol. 30, no. 6, 1 June 2002 (2002-06-01), pages 363 - 365, XP009134665, ISSN: 0253-3758 *
ZHANG LIN ET AL: "Study of autoantibodies against G-protein-coupled beta2- and alpha1-adrenergic and angiotensin II-1 receptors in patients with chronic heart failure", ZHONGHUA ZHONGLIU ZAZHI - CHINESE JOURNAL OF ONCOLOGY, ZHONGHUA YIXUEHUI, BEIJING, CN, vol. 31, no. 1, 1 January 2003 (2003-01-01), pages 17 - 20, XP009134666, ISSN: 0253-3758 *

Also Published As

Publication number Publication date
WO2008080030A2 (en) 2008-07-03
WO2008080030A3 (en) 2008-10-09
JP2010515023A (en) 2010-05-06
MX2009006744A (en) 2009-06-30
CA2669863A1 (en) 2008-07-03
EP2115466A2 (en) 2009-11-11
BRPI0720215A2 (en) 2013-12-24

Similar Documents

Publication Publication Date Title
EP1741186A4 (en) Tensioned touch panel and method of making same
EP1855833A4 (en) Plasmas and methods of using them
EP2122054A4 (en) Nonwoven panel and method of construction thereof
PT2101766T (en) Compositions and methods of using (r)-pramipexole
EP2095098A4 (en) Sample support structure and methods
EP2086318A4 (en) Neuroprotective compositions and methods
IL192419A0 (en) Anti-ephb4 antibodies and methods using same
TWI341406B (en) Diaply panel and its application
IL247957A0 (en) Anti-ephrinb2 antibofies and methods using same
EP2047506A4 (en) Interconnect structure and process of making the same
PL2101766T3 (en) Compositions and methods of using (r)-pramipexole
EP1891407A4 (en) Boost devices and methods of using them
ZA200801156B (en) Fastening spider and method of fastening
EP2115466A4 (en) Cardiovascular autoimmune disease panel and methods of using same
IL190039A0 (en) Supercritical flat panel collector and methods of use
EP2037944A4 (en) Tacrolimus standard and methods of using same
EP2037895A4 (en) Xylitol troches and methods of use
GB0619803D0 (en) Lockerbank structure and method of assembly
IL198413A0 (en) Sugar coatings and methods therefor
GB0707608D0 (en) Improved structural members and structures
IL198566A (en) Laminated panel and methods of producing the same
GB0618608D0 (en) Building and other components
ZA200806053B (en) Anti-EphB4 antibodies and methods using same
GB0625310D0 (en) Yeast platform construction and screening methods
IL192552A0 (en) Dnt-succinate and methods of preparation thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090716

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20100630

17Q First examination report despatched

Effective date: 20140331

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140812